Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+37.5%
5Y CAGR+10.3%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+37.5%/yr
Quarterly compound
5Y CAGR
+10.3%/yr
Recent acceleration
Percentile
P90
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 40.00% |
| Q2 2025 | 35.48% |
| Q1 2025 | -55.00% |
| Q4 2024 | -42.86% |
| Q3 2024 | 0.00% |
| Q2 2024 | 33.33% |
| Q1 2024 | 48.78% |
| Q4 2023 | -17.14% |
| Q3 2023 | 5.41% |
| Q2 2023 | -5.71% |
| Q1 2023 | -181.40% |
| Q4 2022 | 230.30% |
| Q3 2022 | 15.38% |
| Q2 2022 | -18.18% |
| Q1 2022 | 17.50% |
| Q4 2021 | -17.65% |
| Q3 2021 | -1800.00% |
| Q2 2021 | 106.67% |
| Q1 2021 | -3.45% |
| Q4 2020 | 27.50% |
| Q3 2020 | 24.53% |
| Q2 2020 | 20.90% |
| Q1 2020 | 10.67% |
| Q4 2019 | -44.23% |
| Q3 2019 | 8.77% |
| Q2 2019 | -26.67% |
| Q1 2019 | -9.76% |
| Q4 2018 | -70.83% |
| Q3 2018 | -60.00% |
| Q2 2018 | 16.67% |
| Q1 2018 | 0.00% |